{"url":"https://uneyama.hatenadiary.jp/entry/20170829/p2","categories":["FDA"],"image_url":null,"height":"190","version":"1.0","published":"2017-08-29 00:00:01","width":"100%","author_name":"uneyama","title":"FDA\u30b3\u30df\u30c3\u30b7\u30e7\u30ca\u30fcScott Gottlieb\u533b\u5e2b\u306e\u3001\u5e79\u7d30\u80de\u7642\u6cd5\u3068\u518d\u751f\u533b\u7642\u3078\u306e\u9069\u5207\u306a\u76e3\u8996\u3092\u78ba\u4fdd\u3059\u308b\u305f\u3081\u306eFDA\u306e\u65b0\u3057\u3044\u65b9\u91dd\u306e\u524d\u9032\u3068\u57f7\u884c\u306b\u3064\u3044\u3066\u306e\u58f0\u660e","type":"rich","blog_url":"https://uneyama.hatenadiary.jp/","provider_name":"Hatena Blog","author_url":"https://blog.hatena.ne.jp/uneyama/","provider_url":"https://hatena.blog","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20170829%2Fp2\" title=\"FDA\u30b3\u30df\u30c3\u30b7\u30e7\u30ca\u30fcScott Gottlieb\u533b\u5e2b\u306e\u3001\u5e79\u7d30\u80de\u7642\u6cd5\u3068\u518d\u751f\u533b\u7642\u3078\u306e\u9069\u5207\u306a\u76e3\u8996\u3092\u78ba\u4fdd\u3059\u308b\u305f\u3081\u306eFDA\u306e\u65b0\u3057\u3044\u65b9\u91dd\u306e\u524d\u9032\u3068\u57f7\u884c\u306b\u3064\u3044\u3066\u306e\u58f0\u660e - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","description":"Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA\u2019s new policy steps and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine August 28, 2017 https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm573443.htm \uff08\u9577\u3044\u58f0\u660e\u3002FDA\u304c\u65e2\u5b58\u306e\u67a0\u7d44\u307f\u3092\u30d5\u30eb\u6d3b\u7528\u3057\u3066\u65ad\u56fa\u305f\u308b\u53d6\u2026"}